NM_005063.5:c.442-535C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005063.5(SCD):c.442-535C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 152,110 control chromosomes in the GnomAD database, including 5,364 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.24 ( 5364 hom., cov: 33)
Consequence
SCD
NM_005063.5 intron
NM_005063.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.402
Publications
8 publications found
Genes affected
SCD (HGNC:10571): (stearoyl-CoA desaturase) This gene encodes an enzyme involved in fatty acid biosynthesis, primarily the synthesis of oleic acid. The protein belongs to the fatty acid desaturase family and is an integral membrane protein located in the endoplasmic reticulum. Transcripts of approximately 3.9 and 5.2 kb, differing only by alternative polyadenlyation signals, have been detected. A gene encoding a similar enzyme is located on chromosome 4 and a pseudogene of this gene is located on chromosome 17. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.323 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCD | NM_005063.5 | c.442-535C>T | intron_variant | Intron 3 of 5 | ENST00000370355.3 | NP_005054.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCD | ENST00000370355.3 | c.442-535C>T | intron_variant | Intron 3 of 5 | 1 | NM_005063.5 | ENSP00000359380.2 |
Frequencies
GnomAD3 genomes AF: 0.236 AC: 35921AN: 151992Hom.: 5367 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
35921
AN:
151992
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.236 AC: 35916AN: 152110Hom.: 5364 Cov.: 33 AF XY: 0.244 AC XY: 18108AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
35916
AN:
152110
Hom.:
Cov.:
33
AF XY:
AC XY:
18108
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
2267
AN:
41536
American (AMR)
AF:
AC:
3969
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
792
AN:
3468
East Asian (EAS)
AF:
AC:
1736
AN:
5162
South Asian (SAS)
AF:
AC:
1457
AN:
4824
European-Finnish (FIN)
AF:
AC:
4208
AN:
10556
Middle Eastern (MID)
AF:
AC:
61
AN:
292
European-Non Finnish (NFE)
AF:
AC:
20572
AN:
67964
Other (OTH)
AF:
AC:
513
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1325
2649
3974
5298
6623
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1060
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.